Literature DB >> 8447113

The laminins: a family of basement membrane glycoproteins important in cell differentiation and tumor metastases.

H K Kleinman1, B S Weeks, H W Schnaper, M C Kibbey, K Yamamura, D S Grant.   

Abstract

Laminins are a family of basement membrane-derived glycoproteins that are very biologically active with a number of diverse cell types. The response of the cells is dependent on the cell type and various cell-specific intracellular events are activated. Multiple active sites on laminin and cellular receptors have been described. Both laminin and the synthetic peptides that define the active sites may have important clinical uses. For example, the neurite-promoting peptides may be useful in vivo in regeneration studies because of their potent activity with neural cells and their lack of antigenicity. Also, peptides, such as YIGSR, that inhibit angiogenesis are potentially useful for treating the vascularization of the eye that occurs in conditions such as diabetes mellitus. Likewise, the angiogenic peptide SIKVAV, because of its role in endothelial cell block vessel formation, may be useful for treating ischemia. The recent progress that has been made in characterizing basic mechanisms of action of laminin has laid the groundwork for more direct studies of its clinical relevance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8447113     DOI: 10.1016/s0083-6729(08)60446-x

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  15 in total

1.  Diabetes induces changes in glomerular development and laminin-beta 2 (s-laminin) expression.

Authors:  C K Abrass; D Spicer; A K Berfield; P L St John; D R Abrahamson
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  Angiogenic laminin-derived peptides stimulate wound healing.

Authors:  Katherine M Malinda; Annette B Wysocki; Jennifer E Koblinski; Hynda K Kleinman; M Lourdes Ponce
Journal:  Int J Biochem Cell Biol       Date:  2008-06-20       Impact factor: 5.085

Review 3.  Extracellular matrix and the kidney.

Authors:  P N Furness
Journal:  J Clin Pathol       Date:  1996-05       Impact factor: 3.411

4.  Laminin-derived peptide AG73 regulates migration, invasion, and protease activity of human oral squamous cell carcinoma cells through syndecan-1 and beta1 integrin.

Authors:  Adriane S Siqueira; Letícia N Gama-de-Souza; Maria Vanda C Arnaud; João J V Pinheiro; Ruy G Jaeger
Journal:  Tumour Biol       Date:  2009-12-09

5.  Control pathways of the 67 kDa laminin binding protein: surface expression and activity of a new ligand binding domain.

Authors:  T H Landowski; S Uthayakumar; J R Starkey
Journal:  Clin Exp Metastasis       Date:  1995-09       Impact factor: 5.150

6.  Expression of alpha 6 and beta 4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin.

Authors:  A P Skubitz; R C Bast; E A Wayner; P C Letourneau; M S Wilke
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

7.  Basal cell adhesion molecule/lutheran protein. The receptor critical for sickle cell adhesion to laminin.

Authors:  M Udani; Q Zen; M Cottman; N Leonard; S Jefferson; C Daymont; G Truskey; M J Telen
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

8.  Laminin α1 regulates age-related mesangial cell proliferation and mesangial matrix accumulation through the TGF-β pathway.

Authors:  Liang Ning; Hidetake Kurihara; Susana de Vega; Naoki Ichikawa-Tomikawa; Zhuo Xu; Risa Nonaka; Saiko Kazuno; Yoshihiko Yamada; Jeffrey H Miner; Eri Arikawa-Hirasawa
Journal:  Am J Pathol       Date:  2014-04-08       Impact factor: 4.307

9.  Aging-associated changes in renal extracellular matrix.

Authors:  C K Abrass; M J Adcox; G J Raugi
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

10.  Laminin alpha4-null mutant mice develop chronic kidney disease with persistent overexpression of platelet-derived growth factor.

Authors:  Christine K Abrass; Kim M Hansen; Bruce L Patton
Journal:  Am J Pathol       Date:  2009-12-24       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.